Financhill
Back

Opus Genetics Stock Predictions

Opus Genetics Stock Forecast

  • Is Opus Genetics Stock Undervalued?
    The current Opus Genetics [IRD] share price is $1.17. The Score for IRD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • IRD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Opus Genetics Stock Go Up Next Year?

Data Unavailable

Opus Genetics Stock Rating

Data Unavailable

Opus Genetics Stock Price History

Is IRD stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IRD is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
opusgtx.com

52-Week Data

52-Week High:
2.18
52-Week Low:
0.65

Prediction Charts

Market Cap:
69.5M
Price in USD:
1.17
Volume:
210.2K
Beta:
2.91

Technical Analysis

SMA50:
1.01
SMA100:
0.97
SMA200:
1.07
52-Wk Change:
-43.17%

Stock Predictions

  • Is Opus Genetics stock public?
    Yes, Opus Genetics is a publicly traded company.
  • What is the Opus Genetics stock quote today?
    The Opus Genetics stock price is 1.17 USD today.
  • How to buy Opus Genetics stock online?
    You can buy Opus Genetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-27 1.02 0.98 1.03 0.97
Jun-30 0.94 0.94 0.96 0.93
Jul-1 0.92 0.94 1.00 0.90
Jul-2 0.93 0.99 1.03 0.93
Jul-3 1.01 1.00 1.02 0.98
Jul-7 1.00 0.99 1.03 0.98
Jul-8 1.01 1.06 1.08 1.00
Jul-9 1.07 1.11 1.13 1.03
Jul-10 1.12 1.12 1.15 1.10
Jul-11 1.11 1.13 1.13 1.08
Jul-14 1.13 1.11 1.13 1.09
Jul-15 1.11 1.10 1.12 1.09
Jul-16 1.10 1.12 1.13 1.08
Jul-17 1.13 1.17 1.17 1.11

Opus Genetics Earnings

Data Unavailable

Opus Genetics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.36 per share.

* Opus Genetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.